financetom
Business
financetom
/
Business
/
Vecima Networks Announces First U.S.-made Electronics Equipment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vecima Networks Announces First U.S.-made Electronics Equipment
Aug 20, 2024 5:32 AM

08:00 AM EDT, 08/20/2024 (MT Newswires) -- Vecima Networks ( VNWTF ) on Tuesday said its first U.S.-made internet network electronics equipment will roll off the production line next week at MARA Technologies USA's Holly, Michigan manufacturing facility.

The production is part of the Build America Buy America (BABA) requirements for the Broadband Equity Access and Deployment (BEAD) Program, the company said.

MARA Technologies expects to add 100 new U.S. workers to manufacture certain of Vecima's Entra Fiber Access Products.

The US$42.45 billion BEAD program, to expand high-speed Internet access across the U.S., is administered by the Commerce Department's National Telecommunications and Information Administration.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- KITS Eyecare ( KTYCF ) on Wednesday said it swung to a profit in the second-quarter as revenue jumped 26% to a record. The on-line eyeglasses company said its second-quarter came in at $187,000, or $0.01 per share, swinging from a loss of $1.2 million, or $0.04, in the year-prior period. Revenue rose...
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Wednesday it received approval from the European Commission for Adzynma for the treatment of congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder caused by a deficiency in the ADAMTS13 enzyme. Takeda said the EC approval does not have any impact on its consolidated forecast for the...
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Aug 7, 2024
On Tuesday, Emergent BioSolutions Inc. ( EBS ) reported second-quarter 2024 sales of $254.7 million, down 25% year over year, beating the consensus of $190 million. The company reported an adjusted EPS loss of $(2.32), more than double the $(1.05) reported a year ago, missing the consensus of $(0.94). Revenues from Narcan (naloxone HCl) Nasal Spray decreased 10% to $120 million, primarily...
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Aug 7, 2024
11:49 AM EDT, 08/07/2024 (MT Newswires) -- ShaMaran Petroleum ( SHASF ) on Wednesday said it closed the acquisition of TAQA Atrush and the subsequent sale of an indirect interest in Atrush to HKN Energy IV. The two-step transaction announced in January increased ShaMaran's 28% indirect stake in the Atrush oil block in Iraq's Kurdistan region to a 50% working...
Copyright 2023-2025 - www.financetom.com All Rights Reserved